Study Evaluating the Abuse Potential of NEURONTIN® in Healthy Non-drug Dependent, Recreational Opioid Users

NCT05319756 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Abuse Potential

Interventions

DRUG: gabapentin 600 mg
DRUG: gabapentin 1200 mg
DRUG: gabapentin 600 mg and oxycodone HCl 20 mg
DRUG: gabapentin 1200 mg and oxycodone HCl 20 mg
DRUG: oxycodone HCl 20 mg
DRUG: placebo

Sponsor

Viatris Specialty LLC